Tech Center 1600 • Art Units: 1635
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18025749 | RECOMBINANT ADENO ASSOCIATED VIRUS (RAAV) ENCODING GJB2 AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 18338150 | COMPOSITIONS AND METHODS FOR MODIFYING RNA | Non-Final OA | The Regents of the University of California |
| 18246981 | USE OF A DOUBLE-STRANDED DNA CYTOSINE DEAMINASE FOR MAPPING DNA-PROTEIN INTERACTIONS | Non-Final OA | University of Washington |
| 18271618 | METHOD OF GENE DELIVERY TO RETINAL ASTROCYTES | Non-Final OA | The United States Government as Represented by The Department of Veterans Affairs |
| 17921338 | TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1) | Non-Final OA | Duke University |
| 18350077 | METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME | Non-Final OA | Cedars-Sinai Medical Center |
| 18240550 | METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING | Non-Final OA | Inscripta, Inc. |
| 17913728 | FORSKOLIN-INDUCIBLE PROMOTERS AND HYPOXIA-INDUCIBLE PROMOTERS | Non-Final OA | ASKLEPIOS BIOPHARMACEUTICAL, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy